Denemek ALTIN - Özgür
PSBs outperform private peers, again
Business Standard
|September 15, 2025
The banking sector's good run continues, but there are challenges, both on asset and liabilities turf
Public sector banks (PSBs) seem to have made it a habit of putting up a better show than their private peers. After a good performance in the March quarter, they have outshone again in the first quarter of the current financial year (April-June).
Barring Punjab National Bank, year-on-year, every PSB has recorded an increase in net profit in the June quarter. The rise varies between 75.57 per cent (Indian Overseas Bank) and 1.87 per cent (Bank of Baroda).
In contrast, net profit has dipped for at least eight private banks. Among large private banks, Axis Bank Ltd's net profit dropped 3.79 per cent, while IndusInd Bank Ltd posted a 68.21 per cent fall.
Private banks' collective net profit dropped close to 3 per cent, while PSBs' rose 10.62 per cent.
In absolute terms, State Bank of India (SBI) led the charge, with a ₹19,160 crore net profit, followed by HDFC Bank Ltd (₹18,155 crore) and ICICI Bank Ltd (₹12,768 crore). The only other bank that recorded a net profit of at least ₹5,000 crore is Axis Bank (₹6,035 crore). All figures are rounded off.
Only one PSB (Union Bank of India) posted a drop in operating profit. Among private banks, six—led by IndusInd Bank—did so.
While the net profit of private banks as a group shrank in the June quarter, their operating profit rose handsomely, by a wider margin than PSBs'.
HDFC Bank led the show with a ₹35,734 crore operating profit, followed by SBI (₹30,544 crore). Two other banks posted an operating profit of over ₹10,000 crore: ICICI Bank (₹18,746 crore) and Axis Bank (₹11,515 crore).
Despite recording higher operating profit than PSBs, private banks lag behind when it comes to net profit because they have made far higher provisions than PSBs. Their collective provision in the June quarter zoomed to ₹27,661 crore from ₹9,844 crore. In contrast, PSBs' provision dropped to ₹15,918 crore from ₹17,004 crore.
Bu hikaye Business Standard dergisinin September 15, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Business Standard'den DAHA FAZLA HİKAYE
Business Standard
Labour Codes impact: HCL tech profit slips 11%
Q3 top line beats Street estimates, bottom line misses expectations
2 mins
January 13, 2026
Business Standard
New labour Codes, restructuring weigh on TCS earnings
Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.
1 min
January 13, 2026
Business Standard
Black drives the thrill for car buyers
Sees a surge in yearly sales, while white remains practical 'utility king'
2 mins
January 13, 2026
Business Standard
CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS
Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be
2 mins
January 13, 2026
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Listen
Translate
Change font size
